The improved clinical course of persistent tachypnea of infancy with inhaled bronchodilators and corticosteroids
- 14 September 2021
- journal article
- research article
- Published by Wiley in Pediatric Pulmonology
- Vol. 56 (12) , 3952-3959
Abstract
Background: Persistent tachypnea of infancy (PTI) is the most common interstitial lung disease in young children. As no standardized therapeutic guidelines exist, different pharmaceuticals are used to treat PTI; inhaled corticosteroids (ICS) and bronchodilators being mostly used. This observation assessed the effectiveness of bronchodilators and ICS in children with PTI enrolled in the children's interstitial lung diseases (chILD)‐EU Register.Methods: Symptomatic children with PTI were observed according to a predetermined stepwise protocol including bronchodilators as the first choice treatment (6 weeks). In patients with incomplete response, additionally, ICS was given (12 weeks). Signs, symptoms, and pulmonary function were evaluated at three time points: at baseline, 6 (±1) weeks after initiation of bronchodilators, and 12 (±1) weeks after bronchodilators/ICS.Results: Thirty‐one children (median age: 44 months, interquartile range [IQR]: 15–67) were included. The therapy was associated with a significant reduction of tachypnea (53.3% of patients, p = 0.02), exercise intolerance (52.2% of patients, p < 0.001), chest retractions (43.8% of patients, p = 0.04), and crackles (29.2% of patients, p = 0.02). Also, a significant improvement in forced expiratory volume in 1 s (FEV1) (median z score: −2.21 vs. −0.47, p = 0.03), residual volume (RV) (median z score 5.28 vs. 1.07, p = 0.007), RV% total lung capacity (TLC) (median z score: 6.05 vs. 1.48, p = 0.01), sRaw (median z score: 6.6 vs. 4.64, p = 0.01), R5 (median z score: 1.27 vs. 0.31, p = 0.009), and R5–R20 (median: 0.58 vs. 0.26 kPa/(l/s), p = 0.002) was demonstrated.Conclusions: Inhaled bronchodilators and ICS may exert a positive effect on the severity of symptoms and pulmonary function test (PFT) in symptomatic children with PTI. However, a randomized control trial should be conducted to confirm their effectiveness.Keywords
This publication has 39 references indexed in Scilit:
- Abnormal infant pulmonary function in young children with neuroendocrine cell hyperplasia of infancyPediatric Pulmonology, 2012
- A study of the use of impulse oscillometry in the evaluation of children with asthma: Analysis of lung parameters, order effect, and utility compared with spirometryPediatric Pulmonology, 2011
- Familial neuroendocrine cell hyperplasia of infancyPediatric Pulmonology, 2010
- Lung clearance index: Normal values, repeatability, and reproducibility in healthy children and adolescentsPediatric Pulmonology, 2009
- Diffuse Lung Disease in Young ChildrenAmerican Journal of Respiratory and Critical Care Medicine, 2007
- Reference values for respiratory system impedance by using impulse oscillometry in children aged 2–11 yearsClinical Physiology and Functional Imaging, 2006
- Standardisation of the measurement of lung volumesEuropean Respiratory Journal, 2005
- Persistent tachypnea of infancy is associated with neuroendocrine cell hyperplasiaPediatric Pulmonology, 2005
- Task force on chronic interstitial lung disease in immunocompetent childrenEuropean Respiratory Journal, 2004
- Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils, and exhaled nitric oxide levels in patients with asthmaThorax, 1999